Skip Navigation


Brain Advance Access originally published online on October 24, 2008
Brain 2008 131(12):3256-3265; doi:10.1093/brain/awn271
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
131/12/3256    most recent
awn271v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Balosso, S.
Right arrow Articles by Vezzani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balosso, S.
Right arrow Articles by Vezzani, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1β

Silvia Balosso1,*, Mattia Maroso1,*, Manuel Sanchez-Alavez2, Teresa Ravizza1, Angelisa Frasca1, Tamas Bartfai2 and Annamaria Vezzani1

1Laboratory of Experimental Neurology, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy and 2Molecular and Integrative Neurosciences Department (MIND), The Scripps Research Institute, La Jolla, CA, USA

Correspondence to: A. Vezzani, PhD, Laboratory of Experimental Neurology, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via G. La Masa 19, Milan, Italy E-mail: vezzani{at}marionegri.it

Interleukin-1β (IL-1β) is overproduced in human and rodent epileptogenic tissue and it exacerbates seizures upon brain application in rodents. Moreover, pharmacological prevention of IL-1β endogenous synthesis, or IL-1 receptor blockade, mediates powerful anticonvulsive actions indicating a significant role of this cytokine in ictogenesis. The molecular mechanisms of the proconvulsive actions of IL-1β are not known. We show here that EEG seizures induced by intrahippocampal injection of kainic acid in C57BL6 adult mice were increased by 2-fold on average by pre-exposure to IL-1β and this effect was blocked by 3-O-methylsphingomyelin (3-O-MS), a selective inhibitor of the ceramide-producing enzyme sphingomyelinase. C2-ceramide, a cell permeable analog of ceramide, mimicked IL-1β action suggesting that ceramide may be the second messenger of the proconvulsive effect of IL-1β. The seizure exacerbating effects of either IL-1β or C2-ceramide were dependent on activation of the Src family of tyrosine kinases since they were prevented by CGP76030, an inhibitor of this enzyme family. The proconvulsive IL-1β effect was associated with increased Tyr418 phosphorylation of Src-family of kinases indicative of its activation, and Tyr1472 phosphorylation of one of its substrate, the NR2B subunit of the N-methyl-D-aspartate receptor, which were prevented by 3-O-MS and CGP76030. Finally, the proconvulsive effect of IL-1β was blocked by ifenprodil, a selective NR2B receptor antagonist. These results indicate that the proconvulsive actions of IL-1β depend on the activation of a sphingomyelinase- and Src-family of kinases-dependent pathway in the hippocampus which leads to the phosphorylation of the NR2B subunit, thus highlighting a novel, non-transcriptional mechanism underlying seizure exacerbation in inflammatory conditions.

Key Words: experimental epilepsy; glia activation; cytokines; NMDA receptor; inflammation

Abbreviations: 3-O-MS, 3-O-methylsphingomyelin; BSA, bovine serum albumin; NMDA, N-methyl-D-aspartate; DMSO, dimethylsulfoxide; ICE, interleukin-1 converting enzyme; icv, intracerebroventricular; IL-1R1, IL-1 receptor type 1; IL-1β, Interleukin-1β; PBS, phosphate-buffered saline

.

Received June 13, 2008. Revised August 5, 2008. Accepted September 21, 2008.


*These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
K. M. Rodgers, M. R. Hutchinson, A. Northcutt, S. F. Maier, L. R. Watkins, and D. S. Barth
The cortical innate immune response increases local neuronal excitability leading to seizures
Brain, September 1, 2009; 132(9): 2478 - 2486.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. P. Cacheaux, S. Ivens, Y. David, A. J. Lakhter, G. Bar-Klein, M. Shapira, U. Heinemann, A. Friedman, and D. Kaufer
Transcriptome Profiling Reveals TGF-{beta} Signaling Involvement in Epileptogenesis
J. Neurosci., July 15, 2009; 29(28): 8927 - 8935.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.